FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to cardiology. Membrane potential of blood leukocytes is assessed in patients with myocardial infarction on the first day from the onset of the disease and calculating the number of cells (%) with altered membrane potential of mitochondria (R-) of blood leukocytes, showing the degree of reduction of the mitochondrial adaptation resource in ischemia in connection with the development of a cardiovascular accident. Calculation is carried out using the original formula. And at value R- (number of leukocytes with changed membrane potential) ≥ 65%, the presence of LV myocardial dysfunction is diagnosed.
EFFECT: invention enables to establish the presence of myocardial dysfunction on the first day of myocardial infarction, its degree depending on the number of blood leukocytes with altered membrane potential and to predict the development of chronic heart failure in the outcome of myocardial infarction individually in each patient.
1 cl, 1 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE RISK OF PROGRESSING CHRONIC HEART FAILURE IN PATIENTS WITH MYOCARDIAL INFARCTION | 2019 |
|
RU2734671C1 |
| METHOD FOR PREDICTING PROGRESSION OF ANTHRACYCLINE-INDUCED CHRONIC HEART FAILURE IN PATIENTS WITH BREAST CANCER WITHIN 24 MONTHS | 2022 |
|
RU2793672C1 |
| METHOD FOR PREDICTING ADVERSE CARDIOVASCULAR EVENTS FOR A PERIOD OF 12 MONTHS IN PATIENTS WITH CHRONIC HEART FAILURE WITH RECURRENCE OF ANGINA AFTER MYOCARDIAL REVASCULARIZATION | 2018 |
|
RU2677611C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH ACUTE DECOMPENSATION OF ISCHEMIC CHRONIC HEART FAILURE WITH SYSTOLIC DYSFUNCTION OF THE LEFT VENTRICLE OF THE HEART AFTER COMPLETE MYOCARDIAL REVASCULARIZATION | 2021 |
|
RU2770271C1 |
| METHOD FOR PREDICTION OF RESPONSE TO CARDIAC RESYNCHRONISING THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE | 2018 |
|
RU2716479C1 |
| METHOD FOR PREDICTING THE RISK OF DEATH IN PATIENTS ONE YEAR AFTER ACUTE CORONARY SYNDROME AND PERCUTANEOUS CORONARY INTERVENTION | 2022 |
|
RU2791657C1 |
| METHOD FOR PREDICTING RISKS OF PROGRESSION OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION IN PATIENTS WITH NON-OBSTRUCTIVE ATHEROSCLEROSIS OF CORONARY ARTERIES DURING 12 MONTHS OF OBSERVATION | 2023 |
|
RU2804705C1 |
| A METHOD FOR DIAGNOSING HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION IN PATIENTS WITH CORONARY ARTERY DISEASE ON THE BACKGROUND OF NON-OCCLUSIVE ATHEROSCLEROSIS OF THE CORONARY ARTERIES | 2022 |
|
RU2789429C1 |
| METHOD FOR INITIATING PHYSIOLOGICAL MYOCARDIAL REVERSE MYOCARDIAL REMODELING BY INDIVIDUALIZED SELECTION OF THE AEROBIC TRAINING INTENSITY MODE FOR THE PATIENTS WITH CHRONIC CARDIAC FAILURE | 2020 |
|
RU2743810C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF LEFT VENTRICULAR REMODELING AFTER ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION AND HEART FAILURE USING A MULTIVARIATE REGRESSION MODEL | 2022 |
|
RU2806237C1 |
